Compass Therapeutics, Inc. (NASDAQ:CMPX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark N Tompkins Other companies: Matternet Inc (Director · Since at least Sep 30, 2025); Deep Fission, Inc. (Director · Since at least Apr 20, 2022); Deep Isolation Nuclear, Inc. (Director · Since at least Apr 20, 2022); Guerrilla RF, Inc (Director · Mar 5, 2021 – Mar 5, 2021 · Past); Serve Robotics Inc. (Director · Mar 5, 2021 – Mar 5, 2021 · Past); Aeluma, Inc. (Director · Dec 1, 2020 – Dec 1, 2020 · Past); SmartKem, Inc. (Director · Aug 17, 2020 – Aug 17, 2020 · Past); Augmedix Inc (Director · May 13, 2019 – May 13, 2019 · Past) | Director · Jul 29, 2018 – Jul 29, 2018 · Past |
| Mary Ann Gray Other companies: BioAtla, Inc. (Director · Since at least Jun 16, 2022); Keros Therapeutics, Inc. (Director · Since at least Jun 1, 2022); RAPT Therapeutics Inc (Director · Since at least Mar 31, 2022); Palisade Bio, Inc. (Director · Jun 11, 2023 – Nov 21, 2023 · Past) | Director · Since at least Apr 26, 2022 |
| Miranda Toledano Other companies: Entera Bio Ltd. (Chief Executive Officer and Board Member · Since at least Jan 1, 2022); Journey Medical Corporation (Director · Since at least Nov 16, 2021); NexGel, Inc (Director · Sep 9, 2021 – Aug 17, 2023 · Past); Sorrento Therapeutics, Inc. (EVP-Corporate Development · Sep 16, 2016 – Sep 16, 2016 · Past) | Director · Jun 25, 2021 – Jun 25, 2021 · Past |
| Ellen V. Chiniara Other companies: Kymera Therapeutics, Inc. (Chief Legal Officer · Jan 3, 2023 – Mar 3, 2025 · Past); Alexion Pharmaceuticals Inc (EVP & Chief Legal Officer · Feb 12, 2018 – Jul 21, 2021 · Past); Alere Inc (GC, Chief Ethics Officer&Sec · Dec 31, 2010 – Oct 3, 2017 · Past) | Chief Legal Officer and Corporate Secretary, Kymera Therapeutics · Since at least Apr 26, 2022 |
| James Boylan Other companies: CAMP4 Therapeutics Corporation (Director · Since at least Oct 10, 2024); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Immunome, Inc. (Director · Since at least Oct 2, 2023) | Director · Since at least Nov 4, 2022 |
| Richard S. Lindahl Other companies: Emergent BioSolutions Inc. (Executive Vice President · Since at least Mar 26, 2018); The Corporate Executive Board Company (Chief Financial Officer · Mar 27, 2013 – Apr 27, 2015 · Past); SPRINT Corp (Treasurer · Feb 7, 2006 – Aug 4, 2008 · Past) | Executive Vice President, Chief Financial Officer and Treasurer, Emergent BioSolutions · Since at least Apr 21, 2023 |
| Brett Kaplan Other companies: Climb Bio, Inc. (Chief Operating Officer · Aug 26, 2024 – Jan 13, 2025 · Past); Prevail Therapeutics Inc (Chief Financial Officer · Jun 19, 2019 – Jan 22, 2021 · Past) | Director · Sep 10, 2020 – Feb 18, 2022 · Past |
| Thomas J. Schuetz Other companies: Audentes Therapeutics Inc (Director · Jul 19, 2016 – Jan 15, 2020 · Past); Relypsa Inc (Director · Nov 14, 2013 – Sep 1, 2016 · Past) | Chief Executive Officer, Compass Therapeutics · Since at least Jun 17, 2020 |
| Barry Shin Other companies: Trevena, Inc. (Acting COO and CFO · Jun 25, 2019 – Oct 8, 2024 · Past) | Chief Financial Officer · Since at least Dec 9, 2024 |
| Cynthia Sirard Other companies: Cypherpunk Technologies Inc. (Chief Medical Officer · Apr 1, 2020 – Mar 28, 2025 · Past) | Chief Medical Officer · Since at least Jan 2, 2026 |
| Vered Bisker-Leib Other companies: Ayala Pharmaceuticals Inc (Director · Aug 18, 2020 – Jan 19, 2023 · Past) | CHIEF EXECUTIVE OFFICER, Director · Jun 17, 2020 – Feb 8, 2024 · Past |
| Anna Gifford | Chief of Staff · Since at least Nov 2, 2026 |
| Arjun Prasad | Chief Commercial Officer · Since at least Jan 2, 2026 |
| Bing Gong | Chief Scientific Officer · Since at least Mar 5, 2026 |
| Carl Gordon | Founding Member, Managing Partner, and Co-Head of Global Private Equity, OrbiMed Advisors LLC · Since at least Nov 4, 2026 |
| ContactAnna Gifford | Chief of · Since at least Dec 17, 2025 |
| David M Wurzer | Director · Feb 8, 2023 – Feb 8, 2023 · Past |
| Ian Chia | Vice President of Business Development & Strategy · Since at least Nov 4, 2026 |
| James Kranz | Vice President and Head of Chemistry Manufacturing and Controls · Since at least Nov 4, 2026 |
| Jonathan Anderman | Senior Vice President, General Counsel and Corporate Secretary · Since at least Aug 1, 2024 |
| Julie Sunderland | Director · Jun 17, 2020 – Jun 19, 2020 · Past |
| Karin Herrera | Senior Vice President and Head of Clinical Operations · Since at least Nov 4, 2026 |
| Kris Sachsenmeier | Vice President of Translational Sciences · Since at least Nov 4, 2026 |
| Neil Lerner | Senior Vice President, Chief Accounting Officer · Since at least Apr 7, 2025 |
| Philip Ferneau | Managing Partner, Borealis Ventures · Since at least Jun 17, 2020 |
| Susan Kalled | Chief Scientific Officer · May 3, 2021 – Feb 18, 2022 · Past |